Pay in 4 interest-free payments of $6.37 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Increase the dose slowly if your body tolerates it
doi: 10.3724/abbs.2025034 70 ZhouXXuCDongJLiaoL
TLR2 Pep-Orid-Liposome Induced Apoptosis of AML Patient Primary Cells Ex Vivo Ex vivo cytotoxicity assays utilizing primary leukemic cells isolated from patients provide a valuable approach for assessing the therapeutic efficacy of antitumor agents, especially for hematological malignancies
These follow-on patents, also known as secondary patents, mainly consist of formulations, combinations with other drugs, methods of treating different indications that were alreadydisclosed in the main compound patents, and drug delivery devices
US$ 24.27
US$ 29.27
US$ 21.97
US$ 29.42
US$ 27.61
